Holen Sie sich die Stockscreener-App
3.095
5.63%
0.165
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - investingnews.com
Neuronetics, Inc. Integrates TrakStar With AdvancedMD, Inc. To Deliver TMS Care Across Clinical, Operational, And Billing Workflows - marketscreener.com
A magnetic brain-treatment system links to patient records for the first time - Stock Titan
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Neuronetics (STIM) Slips 2.46% to $2.77 as Key Support LoomsSystematic Flow - vinanet.vn
Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash - Stock Titan
Neuronetics (STIM) Results Breakdown: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: The Market Price Declines 1.59% in Latest TradingEarnings Miss Streak - vinanet.vn
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neuronetics (STIM) Q2 2026 Results Show Greenbrook Growth Is Outrunning the Legacy NeuroStar Business - AlphaStreet
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - vinanet.vn
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - vinanet.vn
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics director Jorey Chernett buys $44,240 in company stock By Investing.com - Investing.com Canada
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Narrows Q2 Loss as Greenbrook Growth Drives 9% Revenue Increase - Yahoo Finance
Why is Neuronetics stock surging today? By Investing.com - Investing.com Nigeria
Neuronetics (NASDAQ:STIM) Announces Earnings Results - MarketBeat
Why is Neuronetics stock surging today? - Investing.com
Neuronetics Q2 2026 slides: mental health platform beats on margins - Investing.com
Neuronetics publishes investor presentation on NeuroStar TMS, Greenbrook clinic network strategy - Bitget
Neuronetics Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Neuronetics STIM Draws Buy Rating As Vertical Psychiatry Platform Scales Up - StocksToTrade
Form 8K Neuronetics Inc For: 11 August By Investing.com - Investing.com South Africa
Is Neuronetics Inc (STIM) Positioned for Growth After Q2 Earnings Miss? GF Score: 60/100 - GuruFocus
Neuronetics stock soars 15% on second quarter earnings beat By Investing.com - Investing.com South Africa
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
STIM Looks 11.3% Overvalued on GF Value™ - GuruFocus
0.25%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):